GlassScriptPhysician profile
Chadrick R Evans
NPI 1588956635
$171,892.53
in general payments reported to CMS, 2019-2025
27 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $994 · 2020: $1,357 · 2021: $28K · 2022: $31K · 2023: $61K · 2024: $37K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $85K · Travel and Lodging: $17K · Consulting Fee: $5,850 · Food and Beverage: $2,581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $85,447.50 |
| Travel and Lodging | $16,749.82 |
| Consulting Fee | $5,850.00 |
| Food and Beverage | $2,580.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $167,313.64 | 2021-2025 | Pivox Oblique Lateral Spinal System, Clydesdale Ptc Spinal System, Cd Horizon Spinal System |
| Davol INC. | $1,730.28 | 2019-2024 | Phasix Mesh |
| Medical Device Business Services, INC. | $836.89 | 2019 | |
| Intuitive Surgical, INC. | $793.50 | 2021-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $269.93 | 2020-2023 | Spyglass Discover |
| Takeda Pharmaceuticals U.S.A., INC. | $144.76 | 2020-2025 | Gattex, Eohilia |
| Ethicon US, LLC | $142.92 | 2021-2024 | Echelon Flex, Echelon Endopath, Enseal X1 |
| Polynovo North America LLC | $69.20 | 2021-2024 | Novosorb Btm |
| Myriad Genetic Laboratories, INC. | $65.05 | 2021-2023 | Myrisk |
| Tela Bio, INC. | $56.20 | 2021 | |
| Tei Biosciences INC | $47.90 | 2019 | |
| Merck Sharp & Dohme LLC | $45.98 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $45.30 | 2024 | Exparel |
| Allergan, INC. | $41.19 | 2021 | |
| Organogenesis INC. | $36.90 | 2019-2023 | Puraply |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $33.56 | 2024 | Perclot |
| Z-Medica, LLC | $33.31 | 2019 | |
| Nestle Healthcare Nutrition INC. | $30.58 | 2021 | |
| Csl Behring | $27.28 | 2021 | |
| Medtronic USA, INC. | $23.15 | 2020 | |
| Janssen Biotech, INC. | $20.44 | 2024 | Simponi, Simponi Aria, Tremfya |
| Polarityte, INC. | $19.39 | 2019 | |
| Baudax Bio INC. | $15.70 | 2020 | |
| Depuy Synthes Sales INC. | $15.55 | 2019 | |
| Heron Therapeutics, INC. | $14.11 | 2022 | |
| Kls-Martin L.P. | $10.07 | 2022 | |
| Bolder Surgical LLC | $9.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chadrick Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.